Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, B-Cell × poly ICLC × Clear all

Sponsor

Conditions

Melanoma 6 Glioma 4 Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Metastatic Castration-resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Gliosarcoma 1

Interventions

Rituximab 34 Cyclophosphamide 24 Etoposide 12 Doxorubicin 12 Vincristine 11 Prednisone 11 ibrutinib 9 fludarabine 8 fludarabine phosphate 7 Mycophenolic Acid 5 Inotuzumab Ozogamicin 5 Cytarabine 5 pembrolizumab 4 Peripheral Blood Stem Cell Transplantation 4 Lenalidomide 4 Carmustine 4 CT-P10 4 Brentuximab Vedotin 4 Bortezomib 4 tositumomab I-131 3 tazemetostat 3 obinutuzumab 3 Prednisolone 3 Methylprednisolone 3 Melphalan 3 Ifosfamide 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Diphenhydramine 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡